Lila Biologics

Lila Biologics is a biotechnology company that leverages its LILADD AI-powered protein design engine to develop breakthrough therapeutics for oncology and non-oncology patients. The company focuses on translating AI-designed proteins into medicines, including radioligand therapies, in collaboration with partners like Eli Lilly. They aim to unlock transformative medicines that improve the quality of life for patients with debilitating diseases.